Safety and Efficacy of Interferon γ in Friedreich's Ataxia

This study reports the results of an open-label clinical trial testing the safety and efficacy of recombinant human interferon γ (IFNγ)-1b in a group of 12 young FRDA patients treated for 6 months.

Read the entire article HERE

Privacy Policy      Service Terms      Contact      Charity Navigator